BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38018972)

  • 21. High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage.
    Schraders M; van Reijmersdal SV; Kamping EJ; van Krieken JH; van Kessel AG; Groenen PJ; Hoogerbrugge PM; Kuiper RP
    Cancer Genet Cytogenet; 2009 May; 191(1):27-33. PubMed ID: 19389505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optical Genome Mapping as a Diagnostic Tool in Pediatric Acute Myeloid Leukemia.
    Suttorp J; Lühmann JL; Behrens YL; Göhring G; Steinemann D; Reinhardt D; Neuhoff NV; Schneider M
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical Genome Mapping Reveals the Complex Genetic Landscape of Myeloma.
    Giguère A; Raymond-Bouchard I; Collin V; Claveau JS; Hébert J; LeBlanc R
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of optical genome mapping for detecting chromosomal translocation in clinical cytogenetics.
    Dai P; Zhu X; Pei Y; Chen P; Li J; Gao Z; Liang Y; Kong X
    Mol Genet Genomic Med; 2022 Jun; 10(6):e1936. PubMed ID: 35384386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optical Genome Mapping in Routine Cytogenetic Diagnosis of Acute Leukemia.
    Soler G; Ouedraogo ZG; Goumy C; Lebecque B; Aspas Requena G; Ravinet A; Kanold J; Véronèse L; Tchirkov A
    Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optical genome mapping identifies structural variants in potentially new cancer predisposition candidate genes in pediatric cancer patients.
    Wagener R; Brandes D; Jung M; Huetzen MA; Bergmann AK; Panier S; Picard D; Fischer U; Jachimowicz RD; Borkhardt A; Brozou T
    Int J Cancer; 2024 Feb; 154(4):607-614. PubMed ID: 37776287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive profiling of disease-relevant copy number aberrations for advanced clinical diagnostics of pediatric acute lymphoblastic leukemia.
    Kiss R; Gángó A; Benard-Slagter A; Egyed B; Haltrich I; Hegyi L; de Groot K; Király PA; Krizsán S; Kajtár B; Pikó H; Pajor L; Vojcek Á; Matolcsy A; Kovács G; Szuhai K; Savola S; Bödör C; Alpár D
    Mod Pathol; 2020 May; 33(5):812-824. PubMed ID: 31857684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optical genome mapping identifies clinically relevant genomic rearrangements in prostate cancer biopsy sample.
    Shim Y; Lee J; Seo J; Park CK; Shin S; Han H; Lee ST; Choi JR; Chung BH; Choi YD
    Cancer Cell Int; 2022 Oct; 22(1):306. PubMed ID: 36209207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optical Genome Mapping as an Alternative to FISH-Based Cytogenetic Assessment in Chronic Lymphocytic Leukemia.
    Valkama A; Vorimo S; Kumpula TA; Räsänen H; Savolainen ER; Pylkäs K; Mantere T
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optical Genome Mapping for Comprehensive Cytogenetic Analysis of Soft-Tissue and Bone Tumors for Diagnostic Purposes.
    Baelen J; Dewaele B; Debiec-Rychter M; Sciot R; Schöffski P; Hompes D; Sinnaeve F; Wafa H; Vanden Bempt I
    J Mol Diagn; 2024 May; 26(5):374-386. PubMed ID: 38395407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optical Genome Mapping as a New Tool to Overcome Conventional Cytogenetics Limitations in Patients with Bone Marrow Failure.
    Iriondo J; Gómez A; Zubicaray J; Garcia-Martinez J; Abad L; Matesanz C; Giménez R; Galán A; Sanz A; Sebastián E; González de Pablo J; de la Cruz A; Ramírez M; Sevilla J
    Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optical genome mapping reveals balanced and unbalanced genetic changes associated with tumor-forming potential in an early-stage prostate cancer epithelial subline (M2205).
    Paulraj P; Barrie E; Jackson-Cook C
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2307. PubMed ID: 37902189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of a mosaic CDKL5 deletion and inversion by optical genome mapping ends an exhaustive diagnostic odyssey.
    Cope H; Barseghyan H; Bhattacharya S; Fu Y; Hoppman N; Marcou C; Walley N; Rehder C; Deak K; Alkelai A; ; Vilain E; Shashi V
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1665. PubMed ID: 33955715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients.
    Gerding WM; Tembrink M; Nilius-Eliliwi V; Mika T; Dimopoulos F; Ladigan-Badura S; Eckhardt M; Pohl M; Wünnenberg M; Farshi P; Reimer P; Schroers R; Nguyen HP; Vangala DB
    Int J Cancer; 2022 Jun; 150(12):1998-2011. PubMed ID: 35064925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of cryptic balanced chromosomal rearrangements using high-resolution optical genome mapping.
    Zhang S; Pei Z; Lei C; Zhu S; Deng K; Zhou J; Yang J; Lu D; Sun X; Xu C; Xu C
    J Med Genet; 2023 Mar; 60(3):274-284. PubMed ID: 35710108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL).
    Puiggros A; Ramos-Campoy S; Kamaso J; de la Rosa M; Salido M; Melero C; Rodríguez-Rivera M; Bougeon S; Collado R; Gimeno E; García-Serra R; Alonso S; Moro-García MA; García-Malo MD; Calvo X; Arenillas L; Ferrer A; Mantere T; Hoischen A; Schoumans J; Espinet B
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy and initial clinical evaluation of optical genome mapping in the diagnosis of structural variations].
    Hao N; Zhou J; Li MM; Luo WW; Zhang HZ; Qi QW; Jiang YL; Zhou XY; Yang K; Chen H; Pan HJ; Zhu JT; Liu J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 May; 56(5):632-639. PubMed ID: 35644979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optical genome mapping for prenatal diagnosis: A prospective study.
    Goumy C; Guy Ouedraogo Z; Soler G; Eymard-Pierre E; Laurichesse H; Delabaere A; Gallot D; Bouchet P; Perthus I; Pebrel-Richard C; Gouas L; Salaun G; Salse J; Véronèse L; Tchirkov A
    Clin Chim Acta; 2023 Nov; 551():117594. PubMed ID: 37832906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optical Genome Mapping for Oncology Applications.
    Sahajpal NS; Mondal AK; Hastie A; Chaubey A; Kolhe R
    Curr Protoc; 2023 Oct; 3(10):e910. PubMed ID: 37888957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multisite Assessment of Optical Genome Mapping for Analysis of Structural Variants in Constitutional Postnatal Cases.
    Iqbal MA; Broeckel U; Levy B; Skinner S; Sahajpal NS; Rodriguez V; Stence A; Awayda K; Scharer G; Skinner C; Stevenson R; Bossler A; Nagy PL; Kolhe R
    J Mol Diagn; 2023 Mar; 25(3):175-188. PubMed ID: 36828597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.